Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Potential Complementary Value of Noncontrast and Contrast Enhanced CT Radiomics in Colorectal Cancers.

Badic B, Desseroit MC, Hatt M, Visvikis D.

Acad Radiol. 2018 Jul 30. pii: S1076-6332(18)30313-1. doi: 10.1016/j.acra.2018.06.004. [Epub ahead of print]

PMID:
30072293
2.

Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using 18F-fluoromisonidazole PET/CT: a pilot study.

Supiot S, Rousseau C, Dore M, Cheze-Le-Rest C, Kandel-Aznar C, Potiron V, Guerif S, Paris F, Ferrer L, Campion L, Meingan P, Delpon G, Hatt M, Visvikis D.

Oncotarget. 2018 Jan 13;9(11):10005-10015. doi: 10.18632/oncotarget.24234. eCollection 2018 Feb 9.

3.

The first MICCAI challenge on PET tumor segmentation.

Hatt M, Laurent B, Ouahabi A, Fayad H, Tan S, Li L, Lu W, Jaouen V, Tauber C, Czakon J, Drapejkowski F, Dyrka W, Camarasu-Pop S, Cervenansky F, Girard P, Glatard T, Kain M, Yao Y, Barillot C, Kirov A, Visvikis D.

Med Image Anal. 2018 Feb;44:177-195. doi: 10.1016/j.media.2017.12.007. Epub 2017 Dec 9.

PMID:
29268169
4.

Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy.

Lucia F, Visvikis D, Desseroit MC, Miranda O, Malhaire JP, Robin P, Pradier O, Hatt M, Schick U.

Eur J Nucl Med Mol Imaging. 2018 May;45(5):768-786. doi: 10.1007/s00259-017-3898-7. Epub 2017 Dec 9.

PMID:
29222685
5.

Independent component analysis for rectal bleeding prediction following prostate cancer radiotherapy.

Fargeas A, Acosta O, Ospina Arrango JD, Ferhat A, Costet N, Albera L, Azria D, Fenoglietto P, Créhange G, Beckendorf V, Hatt M, Kachenoura A, de Crevoisier R.

Radiother Oncol. 2018 Feb;126(2):263-269. doi: 10.1016/j.radonc.2017.11.011. Epub 2017 Dec 5.

PMID:
29203291
6.

Tumour functional sphericity from PET images: prognostic value in NSCLC and impact of delineation method.

Hatt M, Laurent B, Fayad H, Jaouen V, Visvikis D, Le Rest CC.

Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):630-641. doi: 10.1007/s00259-017-3865-3. Epub 2017 Nov 25.

7.

Responsible Radiomics Research for Faster Clinical Translation.

Vallières M, Zwanenburg A, Badic B, Cheze Le Rest C, Visvikis D, Hatt M.

J Nucl Med. 2018 Feb;59(2):189-193. doi: 10.2967/jnumed.117.200501. Epub 2017 Nov 24. No abstract available.

8.

FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer.

Lovinfosse P, Polus M, Van Daele D, Martinive P, Daenen F, Hatt M, Visvikis D, Koopmansch B, Lambert F, Coimbra C, Seidel L, Albert A, Delvenne P, Hustinx R.

Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):365-375. doi: 10.1007/s00259-017-3855-5. Epub 2017 Oct 18.

PMID:
29046927
9.

A framework based on hidden Markov trees for multimodal PET/CT image co-segmentation.

Hanzouli-Ben Salah H, Lapuyade-Lahorgue J, Bert J, Benoit D, Lambin P, Van Baardwijk A, Monfrini E, Pieczynski W, Visvikis D, Hatt M.

Med Phys. 2017 Nov;44(11):5835-5848. doi: 10.1002/mp.12531. Epub 2017 Oct 9.

10.

Evaluation of the tumor registration error in biopsy procedures performed under real-time PET/CT guidance.

Fanchon LM, Apte A, Schmidtlein CR, Yorke E, Hu YC, Dogan S, Hatt M, Visvikis D, Humm JL, Solomon SB, Kirov AS.

Med Phys. 2017 Oct;44(10):5089-5095. doi: 10.1002/mp.12334. Epub 2017 Jul 12.

PMID:
28494089
11.

Toward a standard for the evaluation of PET-Auto-Segmentation methods following the recommendations of AAPM task group No. 211: Requirements and implementation.

Berthon B, Spezi E, Galavis P, Shepherd T, Apte A, Hatt M, Fayad H, De Bernardi E, Soffientini CD, Ross Schmidtlein C, El Naqa I, Jeraj R, Lu W, Das S, Zaidi H, Mawlawi OR, Visvikis D, Lee JA, Kirov AS.

Med Phys. 2017 Aug;44(8):4098-4111. doi: 10.1002/mp.12312. Epub 2017 Jul 2.

12.

Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.

Hatt M, Lee JA, Schmidtlein CR, Naqa IE, Caldwell C, De Bernardi E, Lu W, Das S, Geets X, Gregoire V, Jeraj R, MacManus MP, Mawlawi OR, Nestle U, Pugachev AB, Schöder H, Shepherd T, Spezi E, Visvikis D, Zaidi H, Kirov AS.

Med Phys. 2017 Jun;44(6):e1-e42. doi: 10.1002/mp.12124. Epub 2017 May 18.

13.

Radiomics in PET/CT: More Than Meets the Eye?

Hatt M, Tixier F, Visvikis D, Cheze Le Rest C.

J Nucl Med. 2017 Mar;58(3):365-366. doi: 10.2967/jnumed.116.184655. Epub 2016 Nov 3. No abstract available.

14.

18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer.

Lasnon C, Majdoub M, Lavigne B, Do P, Madelaine J, Visvikis D, Hatt M, Aide N.

Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2324-2335. Epub 2016 Jun 21.

15.

Reliability of PET/CT Shape and Heterogeneity Features in Functional and Morphologic Components of Non-Small Cell Lung Cancer Tumors: A Repeatability Analysis in a Prospective Multicenter Cohort.

Desseroit MC, Tixier F, Weber WA, Siegel BA, Cheze Le Rest C, Visvikis D, Hatt M.

J Nucl Med. 2017 Mar;58(3):406-411. doi: 10.2967/jnumed.116.180919. Epub 2016 Oct 20.

16.

Haralick textural features on T2 -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer.

Gnep K, Fargeas A, Gutiérrez-Carvajal RE, Commandeur F, Mathieu R, Ospina JD, Rolland Y, Rohou T, Vincendeau S, Hatt M, Acosta O, de Crevoisier R.

J Magn Reson Imaging. 2017 Jan;45(1):103-117. doi: 10.1002/jmri.25335. Epub 2016 Jun 27.

PMID:
27345946
17.

Erratum to: Development of a nomogram combining clinical staging with 18F-FDG PET/CT image features in non-small-cell lung cancer stage I-III.

Desseroit MC, Visvikis D, Tixier F, Majdoub M, Perdrisot R, Guillevin R, Le Rest CC, Hatt M.

Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1933. No abstract available.

PMID:
27325234
18.

Characterization of PET/CT images using texture analysis: the past, the present… any future?

Hatt M, Tixier F, Pierce L, Kinahan PE, Le Rest CC, Visvikis D.

Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):151-165. Epub 2016 Jun 6. Review.

19.

Performance of automatic image segmentation algorithms for calculating total lesion glycolysis for early response monitoring in non-small cell lung cancer patients during concomitant chemoradiotherapy.

Grootjans W, Usmanij EA, Oyen WJ, van der Heijden EH, Visser EP, Visvikis D, Hatt M, Bussink J, de Geus-Oei LF.

Radiother Oncol. 2016 Jun;119(3):473-9. doi: 10.1016/j.radonc.2016.04.039. Epub 2016 May 10.

PMID:
27178141
20.

(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status.

Lovinfosse P, Koopmansch B, Lambert F, Jodogne S, Kustermans G, Hatt M, Visvikis D, Seidel L, Polus M, Albert A, Delvenne P, Hustinx R.

Br J Radiol. 2016 Jul;89(1063):20160212. doi: 10.1259/bjr.20160212. Epub 2016 May 5.

Supplemental Content

Support Center